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Carotid endarterectomy in the acute phase of
crescendo cerebral transient ischemic attacks is safe
and effective
Guy Leseche, MD,a Jean-Marc Alsac, MD,a Yves Castier, MD,a Francis Fady, MD,a
Philippa C. Lavallee, MD,b Mikael Mazighi, MD,b and Pierre Amarenco, MD,b Paris, France
Objective: To document the 30- and 90-day outcomes in patients with severe internal carotid artery stenosis who
underwent carotid endarterectomy in the acute phase of crescendo cerebral transient ischemic attacks (CcTIAs).
Methods: From January 2003 to December 2009, data from patients suffering CcTIAs with an ipsilateral severe internal
carotid artery stenosis and consecutively operated in our department were prospectively collected. CcTIA patients
operated in the acute phase were those who had experienced >two cerebral TIAs and had been consecutively operated
within 2 weeks of their first-ever TIA. Clinical assessment was by the vascular neurologist. Duplex ultrasonography was
initially used for the diagnosis of severe (>70%) ipsilateral internal carotid artery and further assessed by magnetic
resonance angiography and/or computed tomography angiography. Brain damage was assessed by magnetic resonance
imaging or at default computed tomography scan. Perioperative medical treatment and operative techniques were
standardized. Stroke, death, and major cardiac events were analyzed.
Results: Sixty-four patients sustained a median of four cerebral TIAs. Median delay to surgery from initial examination
was 5 days. Themean degree of internal carotid artery stenosis was 87.9%. Of the 55 patients who hadmagnetic resonance
imaging with diffusion-weighted imaging, 43 (78%) patients had new acute infarction in an area that corresponded to the
clinical symptoms. All patients received antiplatelet therapy and statin during the intervening period. All patients
underwent conventional carotid endarterectomy (CEA) with patch angioplasty (polytetrafluoroethylene). Fifty-six
patients (87.5%) underwent CEA under local anesthesia with two (3.5%) utilizing selective shunting, and eight patients
had general anesthesia with systematic shunting. From CEA to discharge, all patients had complete recovery of their
unstable clinical syndrome. At discharge and at 1 and 3months postoperatively, no stroke or death, or major cardiac event
occurred in this series with a 100% complete follow-up.
Conclusions: Short delay between symptom onset and neurological assessment, immediate start of secondary stroke
prevention, optimal perioperative medical treatment, and standardized operative techniques enabled performance of CEA
in the acute phase of CcTIAs with low combined risk of stroke, death, and major cardiac event. ( J Vasc Surg 2011;53:
637-42.)
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cLarge randomized controlled trials have shown that
carotid endarterectomy (CEA) reduces the risk of stroke in
patients with recently symptomatic severe internal carotid
artery stenosis.1 Pooled individual patients data from ran-
domized controlled trials also demonstrated that benefit
from endarterectomy depends not only on the degree of
carotid stenosis but also on specific angiographic and clin-
ical characteristics such as delay to surgery after the present-
ing event. Ideally, the procedure should be done within 2
weeks of the patient’s last symptoms.2 However data from
randomized trials supporting the use of early CEA in pa-
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doi:10.1016/j.jvs.2010.09.055ients with crescendo cerebral transient ischemic attacks
CcTIA) is lacking. In such patients, some small institu-
ional studies have reported very high operative risks,3
hereas others have suggested that the risk is similar to that
or stable symptoms.4 Recently, a systematic review of 28
eries of the English-language literature has shown that the
ooled stroke and stroke/death rates following early ca-
otid surgery in patients with crescendo transient ischemic
ttacks are higher than that of an elective procedure.5
owever, these series report on a small number of patients
ver a long period of time and were case series of low
ethodological quality, suffering from both selection and
nformation bias. The purpose of this study was to docu-
ent the 30- and 90-day perioperative results of CEA in
atients with high-grade internal carotid artery stenosis
uffering ipsilateral CcTIAs and consecutively operated in
ur department within 2 weeks of their first-ever transient
schemic attack (TIA) over the last 7 years.
ETHODS
From January 2003 to December 2009, data from
atients presenting to our medical attention, via our TIA
linic, with CcTIAs and ipsilateral high-grade internal ca-
otid artery (ICA) stenosis and consecutively operated in
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March 2011638 Leseche et alour department within 2 weeks of their first-ever TIA were
prospectively collected. These data included demographics,
risk factors and medical history, current medication, type
and duration of symptoms, preoperative workup, and op-
erative details including plaque morphology description,
perioperative morbidity, and clinical and ultrasonography
follow-up.
TIA was defined as an acute loss of focal cerebral or
ocular function with symptoms that lasted 24 hours and
that were attributed to inadequate blood supply.6 Symp-
toms thought to be consistent with TIA were those defined
by an ad hoc committee.7 Crescendo TIAs were defined as
disabling, recurrent transient cerebral or ocular ischemia
characterized by an increased frequency, duration, or sever-
ity of events.8 For the purposes of this study, (a) patients
with only ocular ischemic events were excluded, because
patients with only ocular ischemic events have a low risk of
stroke on medical treatment consistent with a similarly low
risk of perioperative stroke,9 and (b) early operated CcTIA
patients were those who had experienced2 cerebral TIAs
and had been consecutively operated in our department
within 2 weeks of their first-ever TIA. CEA was performed
as soon as possible after standardized preoperative assess-
ment, diagnosis, and initiation/modification of what we
believed to be the most appropriate medical treatment.10
Delay to surgery for the individual patient had been influ-
enced only by logistical constraints and not clinical reason.
Our TIA clinic program with round-the-clock access to
assessment, diagnosis, and immediate treatment was estab-
lished in close collaboration with a vascular neurologist, a
neuroradiologist, and vascular surgeons, and has been pre-
viously described.10 Briefly, clinical assessment was by the
vascular neurologist; if TIA was suspected, further compre-
hensive tests were initiated in the stoke unit. Brain imaging
(either magnetic resonance imaging [MRI] with diffusion-
weighted imaging or at default computed tomography
[CT] scan) was done by staff in the radiological department
of Bichat-Claude Bernard University Hospital. If the brain
CT orMRI scans revealed an acute infarction in an area that
corresponded to the clinical symptoms, the patient was
judged to have TIA with a new lesion. Duplex ultrasonog-
raphy was initially used to detect high-grade (70%) ca-
rotid stenosis, and echocardiography was done to exclude a
high-risk cardiac source of embolism. All vascular neurolo-
gists who participated in this program were fully trained in
ultrasound. In most cases, high-grade internal carotid ar-
tery stenosis was further assessed by MR angiography
and/or CT angiography. Conventional angiography was
performed only when carotid artery occlusion was sus-
pected on noninvasive tests or when noninvasive tests were
not in agreement or inconclusive. Severity of stenosis was
computed with the method of the North American Symp-
tomatic Carotid Endarterectomy Trial.11 Antiplatelet ther-
apy and statin, and, as indicated, antihypertensive and
antidiabetic therapy was prescribed or modified immedi-
ately for all patients. Anticoagulant therapy with heparin or
low-molecular-weight heparin was left to the discretion of
the vascular neurologist. Patients at risk for coronary dis- case were appropriately -blocked. After diagnosis and
rimary treatment, the vascular surgical team was alerted to
stablish the indication for and timing of CEA as soon as
he logistical constraints were resolved. Surgery was rou-
inely performed under local anesthesia with simple super-
cial block. Occasionally, CEA was performed under gen-
ral anesthesia. Operative technique was standardized.
Heparin reversion with protamine was left to the dis-
retion of the operator. After CEA, patients remained in an
ntensive care setting for 6 to 12 hours (or more depending
n comorbid conditions) where postoperative blood pres-
ures were maintained to normal or slight subnormal val-
es. Members of the anesthesiology department and a
ascular neurologist, when required, performed initial in-
atient neurologic examination and clinical management.
he main outcome measures were stroke, death, and major
ardiac events. Any new neurologic deficit lasting 24
ours was classified as a stroke. Major cardiac events were
efined as Q and non-Q wave myocardial infarction (MI),
ongestive heart failure, unstable angina, and ventricular
achyarrhythmias. MI was defined as including two or more
f the following criteria: troponin concentration 1.3
g/L, ischemic change on electrocardiogram (ECG), or
hest pain for 30 minutes. Non-Q wave MI was defined
s elevated troponin concentration with no ECG changes.
ardiac enzyme assays were not obtained routinely and
ere only requested in patients at risk, and if there were
linical symptoms, ST segment changes, or hemodynamic
nstability. From the day of the procedure to discharge from
he hospital, all patients received low molecular weight
eparin at a prophylactic dose (Nadroparin, 3075 anti-
actor Xa IU/d). After discharge, only aspirin and/or
lopidogrel was continued. Follow-up neurologic examina-
ion was performed in our department by the vascular
eurologist/surgeon on the day of discharge and by the
ascular neurologist at 1, 3, and 6 months of follow-up,
hen yearly. Follow-up ultrasonography was performed in
ur department by the angiology team on the day of
ischarge and subsequently by the vascular neurologist
eam at 1, 3, and 6 months and then yearly. Residual/
ecurrent stenosis was defined as reduction in vessel diam-
ter of more than 50% (peak systolic velocity 140 cm/s).
ESULTS
Over the past 84 months, 663 patients underwent
arotid revascularization in our department. Of these, 64
9.6%) consecutive patients with high-grade ICA stenosis
nderwent CEA in the acute phase of ipsilateral crescendo
erebral TIAs. These 64 patients (51 men, 13 women;
edian age of 72 years; range, 41 to 93 years) sustained a
edian of four cerebral TIAs (range, 2-30). Thirteen pa-
ients experienced two TIAs, 18 experienced three TIAs,
nd 33 four or more TIAs. Median delay to surgery from
nitial examination was 5 days (interquartile range, 2-10
ays). Baseline characteristics and medical history are pre-
ented in Table I. Forty-six (72%) patients had hypercho-
esterolemia, as defined by medical history or a blood
holesterol concentration of 6.21 mmol/L or more. Forty-
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Volume 53, Number 3 Leseche et al 639five (70%) patients had hypertension, as defined by medical
history of hypertension or blood pressure of more than
140/90 mm Hg. All patients had at least one vascular risk
factor (ie, had a body mass index 30 kg/m2, hyperten-
sion, hypercholesterolemia, diabetes, or a history of cardio-
vascular and cerebrovascular diseases, or were smokers), 34
(53%) patients had one to three vascular risk factors, and 30
(47%) patients had four to six vascular risk factors. Sixty-
two (97%) patients had brain imaging; 55 (86%) had MRI,
and 45 (68%) had CT scans. All patients received duplex
ultrasonography. Fifty-one (80%) patients hadMR angiog-
raphy, 18 (28%) patients had CT angiography, and two
patients had conventional angiography. Of the 55 patients
who had MRI with diffusion-weighted imaging, 43 (78%)
patients had an acute infarction in the area that corre-
sponded to the clinical symptoms. Thirty-three stenoses
(51.5%) were left-sided. Mean grade of internal carotid
artery stenosis was 87.9%  9.2%. Forty-nine patients
(76.5%) had stenosis 80% (12 preocclusive and 32
90%). Among these 49 patients, 16 (33%) had contralat-
eral carotid stenosis 60%, and two had contralateral ca-
rotid occlusion. Among the remaining 15 patients with
stenosis 80%, three had contralateral carotid stenosis of
95%, 70%, and 65%, respectively; and two more patients
experienced contralateral CEA, one for asymptomatic 85%
stenosis, and one for cerebral TIA 32 months before onset
of the new cerebral qualifying events. Among the 64 pa-
tients, sixteen (25%) patients had 60% or greater extracra-
nial posterior circulation disease, and seven of these patients
had complete occlusion of one (n  6) or two (n  1)
vertebral arteries. Intracranial atherosclerotic disease was
not analyzed in this study. All patients received antiplatelet
Table I. Baseline characteristics and medical history
Median age (years) 72 (41-93) (Age 70, n  36;
80, n  11)
Male gender 51 (79.5%)
Hypercholesterolemia 46 (72%)
Hypertension 45 (70%)
Smokers (current or ex) 39 (61%)
Diabetes 19 (30%)
Previous stroke/TIA 14 (22%)
Obesity 13 (20%)
Chronic lung disease 13 (20%)
Symptomatic peripheral
arterial disease 13 (20%)
Previous myocardial infarction 12 (19%)
Coronary heart disease 12 (19%)
CABG  4
PCI  5
CABG  PCI  1
Renal impairment 11 (17%)
Angina pectoris 10 (16%)
Atrial fibrillation 9 (14%)
Cardiac failure 4 (6%)
ASA grade II or III or IV 64 (100%)
ASA, American Society of Anesthesiologists;CABG,Coronary artery bypass
grafting, PCI, percutaneous coronary intervention; TIA, transient ischemic
attack.therapy and statin during the intervening period and post- speratively. All but eight patients received anticoagulant
herapy with heparin stopped 2 hours prior to the operation
r low-molecular-weight heparin. Six patients received
ouble antiplatelet therapy with aspirin and clopidogrel,
nd two patients had a switch from aspirin to clopidogrel.
eri-operative antithrombotic therapies are presented in
able II. From admission to CEA, 15 (23%) patients expe-
ienced new sporadic TIAs despite what we thought to be
ptimal antithrombotic therapy (heparin and aspirin or
lopidogrel in all 15 patients). Fifty-six patients (87.5%)
nderwent CEA under local anesthetic with two (3.5%)
tilizing selective shunting because of loss of consciousness
mmediately (few seconds) after clamping. These two 82-
nd 79-year-old patients had a 75% and 80% carotid steno-
is, respectively, and one had an acute new infarction on
iffusion-weighted imaging. Neither of these two patients
ad contralateral carotid stenosis nor vertebral artery ste-
osis. There was no complication related to superficial
lock and no conversion to general anesthesia. Eight pa-
ients (12.5%) underwent CEA under general anesthesia
ith systematic (100%) shunting. General anesthesia was
he result of medical decision in three cases (obesity [body
ass index  36], n  1; understanding deemed insuffi-
ient, n 2) and of patient’s decision in five cases (anxiety,
 4; claustrophobia, n  1). The operative details are
ummarized in Table III. At operation, macroscopic exam-
nation of the plaques revealed soft and friable atheroma in
9 (76.5%) patients and/or ulcerated plaques with overly-
ng debris or thrombus in 82% of patients. From CEA to
ischarge, all patients had complete recovery of their un-
able II. Perioperative antithrombotic therapy
eparin/low molecular weight heparin stopped 2
hours before surgery with one antiplatelet
therapy 56 (87.5%)
spirin  clopidogel without heparin 6 (9.3%)
lopidogel without heparin 2 (3.1%)
ntraoperative heparin 50 IU/kg before clamping 64 (100%)
able III. Operative details
ocal anesthesia 56 (87.5%)
eneral anesthesia 8 (12.5%)
ype of surgery
Longitudinal endarterectomy  patch
angioplasty (PTFE)
64 (100%)
laque morphology
Soft-friable atheroma 49 (76.5%)
Ulceration  overlying debris/thrombus 40 (74%)
Intra-plaque hemorrhage 25 (39%)
uration of surgery (minutes) 104 (72-125)
lamping time (minutes) 45 (31-55)
hunting 10 (15.5%)
Systematic shunting under general
anesthesia
8 (100%)
Elective shunting under local anesthesia 2 (3.5%)
Shunting time (minutes) 39 (29-50)
TFE, Polytetrafluoroethylene.table clinical syndrome. Patients were discharged after a
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March 2011640 Leseche et almedian of 3 days postoperatively (range, 2-9 days). At
discharge and at 1 and 3months postoperatively, no stroke,
death, or major cardiac event occurred in this series with a
100% complete follow-up. There was no reoperation for
cervical hemorrhage or wound infection. One patient had a
temporary hypoglossal nerve injury that completely recov-
ered within 30 days of CEA. There was no residual/
recurrent stenosis on duplex imaging follow-up.
DISCUSSION
The results of our study suggest that CEA in the acute
phase, for patients presenting to medical attention with
CcTIAs and high-grade internal carotid artery stenosis, can
be performed with low combined risk of stroke, death, and
major cardiac event. Furthermore, our study documents
the effectiveness of rapid assessment and management in
such patients and demonstrates that these services can be
provided on a local level. Although the number of cases
reported in this series is small, it is, to the best of our
knowledge, the largest surgical series described in the liter-
ature with accurate data on contemporary patients consec-
utively operated upon in a single institution. We assume
that our results might be explained by the following rea-
sons: (a) short delay between symptom onset and neuro-
logical assessment; (b) immediate start of secondary stroke
prevention; (c) short time study period of contemporary
patients where optimal medical treatment was well estab-
lished; and (d) standardized operative techniques per-
formed by trainee surgeons and anesthetists.
Recent advances in stroke prevention have placed ma-
jor emphasis on rapid-access TIA clinics in an attempt to
reduce stroke risk after a transient cerebral or retinal isch-
emia.10,12 TIAs precede up to a quarter of completed
strokes,13 and so give clinicians an opportunity to avoid a
completed stroke and its devastating and sometimes fatal
consequences. In most cases of cerebral TIAs, diffusion-
weighted imaging shows the presence of acute ischemic
tissue damage.14 Thus, cerebral TIAs can be thought of as
mini strokes and as medical emergencies. Because patients
with only ocular ischemic events have a low risk of stroke on
medical treatment consistent with a similarly low risk of
perioperative stroke,9 they were excluded from this study,
and only patients who experienced CcTIAs were studied.
CcTIAs have a somewhat subjective definition,5 but it
is a widely recognized clinical syndrome that faces practi-
tioners with challenging problems. Although, the natural
history of CcTIAs has not been evaluated prospectively, it is
reasonable to assume that the risk of CcTIAs is at least
equivalent to, if not worse than, the risk of a single episode
of cerebral TIA. A population-based study15 showed that
the risk of stroke after a TIA or minor stoke in patients with
50% carotid artery stenosis was 21% (8%-34%) at 2 weeks
and 32% (17%-47%) at 12 weeks, in half of which the
strokes were disabling or fatal. In this series, 49 (76.5%)
patients had ipsilateral carotid stenosis 80%, and 78% of
patients who received diffusion-weighted imaging had an
acute infarction, and we thought that early operation was
indicated. However, the key question for such patients is to that extent the absolute benefits and risks of surgery are
ncreased by early operation.
The rationale for early surgery for CcTIA patients
resenting with severe ipsilateral carotid stenosis is to re-
tore blood flow, to stop clinical fluctuation or progressive
eurological impairment, and to reduce the risk of recur-
ent stroke, the latter being the highest within 2 weeks after
he onset of first-ever TIA.
As suggested in this series, and reported in others8,16,17
edical treatment alone in such patients has, at best, an
npredictable outcome and, at worst, a poor prognosis,
ith a significant number of patients suffering a completed
troke within a short interval. On the other hand, carotid
urgery in the acute phase had been considered as risky in
he past, although several institutional studies have re-
orted excellent results.4 Therefore, some practitioners
ave long been reluctant to undertake urgent carotid revas-
ularization because of the fear of increased risk of periop-
rative stroke and death. Ischemic stroke (and related
eath) is by far the most common complication following
EA. Although many studies have identified various indi-
idual preoperative risk factors, few have focused on the
ause of perioperative strokes. Riles et al18 were the first to
how that most perioperative strokes were due to technical
rrors/imperfections and that mechanisms attributable to
echnical errors (thrombosis, embolism, ischemia, etc) ac-
ounted for most perioperative strokes regardless of the
atient’s preoperative neurologic status. Like many other
niversity referral centers, we are convinced that operative
echniques and optimal perioperative medical treatment
lay a fundamental part in minimizing the operative risk
nd that most perioperative strokes are technically prevent-
ble. However, while optimal medical treatment with anti-
latelet, statins, and cardioprotective pharmacotherapy is
ell established,19-23 the benefits of employing various
perative techniques when performing CEA are still con-
roversial because few if any powered randomized clinical
rials have evaluated these techniques. In our department,
e routinely perform CEA under either general or local
nesthesia. However, we and others24-29 are convinced
hat, in patients with multiple-severe comorbidities (high
eneral risk patients) and/or severe contralateral carotid
teno-occlusive disease (high local risk patients), local an-
sthesia with a simple superficial block has several advan-
ages over regional or general anesthesia, and that local
nesthesia has contributed to the good results observed in
his series. Although the expected benefit of local anesthe-
ia was not significant in the recent General Anaesthesia
ersus Local Anaesthesia for Carotid Endarterectomy
GALA) trial30 nor in other six previous randomized tri-
ls,28 it must be admitted that the GALA trial had several
iases, and that randomized trials are not adapted to show
significant difference between the two anesthetic tech-
iques since, before randomization, patients must be
eemed suitable to be operated upon with the two tech-
iques, which introduces a bias for non-randomization of
atients who are most at risk; that is to say precisely those
he most likely to benefit from local anesthetic.
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Volume 53, Number 3 Leseche et al 641To further minimize perioperative strokes, we relied
on: (a) extra exposure when shunts are planned or selec-
tively used, to avoid delays in shunt placement and shunt
complication; (b) early clamping of the common and ex-
ternal carotid arteries before dissection of the carotid bulb
and the internal carotid artery to prevent embolization
during carotid artery dissection; (c) long arteriotomies, to
allow close and direct assessment of the entire endarterec-
tomized site; and (d) systematic patch angioplasty. Carotid
patch angioplasty has long been proven to be associated
with a reduction in the combined risk of stroke, death, and
arterial occlusion during the perioperative period.31 Inter-
estingly, it should be noted that in GALA, a minority of
arteries were patched, and that significantly fewer arteries
were patched in the local anesthesia group (42% vs 50%, P
 .001), which might have increased the risk of neurolog-
ical complications in this group. Although completion eval-
uation of the results of CEA has been advocated to improve
the results of surgery, and although intraoperative ultra-
sound controls were routinely performed in this series, we
feel that objective intraoperative assessment with close and
direct vision of the entire site of CEA is the most accurate
method to identify (and correct) technical defects or im-
perfection provided the technique of endarterectomy al-
lows assessment of the entire endarterectomized site. Oth-
erwise, selective intraoperative angiography should be
performed.
The strengths of our study include its prospective de-
sign with collection of highly detailed clinical information
on more than 80 different clinical, radiographic, surgical,
anesthesia, and medical management variables; the system-
atic review of all patients by a vascular neurologist; and the
absence of loss to follow-up in the 30- and 90-day periop-
erative period. Another strength is that patient selection
was not based on age or comorbid illness burden, and that
delay to surgery for the individual patient was influenced
only by logistical constraints, which means that our study
represents real-world practice. However, our study also has
several limitations. First, recruitment via our TIA clinic has
some biases that have been previously discussed.10 Second,
our department is high-volume with respect to carotid
endarterectomy and includes a teaching university pro-
gram, so the extent to which our findings can be extrapo-
lated to other settings is unclear. Third, we had no histor-
ical controls and did not randomize patients to CEA in the
acute phase versus delayed CEA. Fourth, it may be that the
conclusions of the present study could simply represent a
statistical error because of the small numbers. The latter was
the reason why a formal statistical analysis for any potential
significant variables with impact on outcome was not per-
formed.
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